Identity
- Trade Name
- Integre Duo Pro Red/Green FDA UDI
- Generic Name
- Ophthalmic solid-state laser system FDA UDI
- Model / Reference
- LP1RG FDA UDI
Identifiers
- Primary DI / UDI-DI
- 09342395000106 FDA UDI
- 510(k) Number
- K081565 FDA UDI
- FDA Product Code
- HQF FDA UDI
- GMDN Term
- Ophthalmic solid-state laser system FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 886.4390 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
Yes
FDA UDI
Category: Ophthalmic solid-state laser system
Integre Duo Pro Red/Green by Ellex Medical Pty Ltd — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Ophthalmic solid-state laser system.
- Eagle — Belkin Vision, Ltd. · Class II
- EASYRET — QUANTEL MEDICAL · Class II
- 25ga Straight Laser Probe — Vortex Surgical, Inc. · Class II
- Voyager DSLT — Belkin Vision, Ltd. · Class II
- TruScan Pro — Lightmed Corp. · Class II
- Smart-V Illumination Add-on — Lumenis Be, Inc. · Class II
- PASCAL Synthesis, 577nm — Iridex Corporation · Class II
- VISULAS green — Carl Zeiss Meditec AG · Class II
Cleared under the same submission
K081565 also covers:
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Ellex Medical Pty Ltd
Sources (1)
- FDA UDI fd30bb8b-31a2-4d27-8b8d-bba41f6ab09c 33 fields · synced Jun 6, 2026